Citius Pharmaceuticals Ownership 2024 | Who Owns Citius Pharmaceuticals Now?
Institutional Ownership
1.75%
Insider Ownership
6.81%
Retail Ownership
91.44%
Institutional Holders
33.00
Citius Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6.38% | 0.07% | 10,156,000 | 10,156,000 | 100.00% | 5,928,057 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.98% | 0.00% | 6,327,257 | -677,862 | -9.68% | 3,693,220 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.29% | 0.00% | 2,048,860 | 2,048,860 | 100.00% | 1,195,920 | Jun 30, 2024 |
| BLACKROCK INC. | 1.14% | - | 1,805,726 | -6,920,767 | -79.31% | 1,054,002 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.03% | 0.00% | 1,646,297 | -1,299,197 | -44.11% | 961,171 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.75% | 0.00% | 1,186,559 | 1,099,074 | 1256.30% | 692,595 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.66% | 0.00% | 1,055,038 | -65,251 | -5.82% | 615,826,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.59% | 0.00% | 932,333 | - | - | 544,066 | Jun 30, 2024 |
| STATE STREET CORP | 0.37% | - | 581,797 | -1,627,767 | -73.67% | 339,595,000 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.24% | 0.01% | 389,469 | 389,469 | 100.00% | 227,333 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 275,000 | 275,000 | 100.00% | 160,518 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.15% | 0.00% | 230,970 | 230,970 | 100.00% | 134,818 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.14% | 0.00% | 215,020 | 5,165 | 2.46% | 126,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.13% | 0.02% | 201,876 | 201,876 | 100.00% | 117,835 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.10% | - | 159,422 | 107,227 | 205.44% | 92,943 | Jun 30, 2024 |
| INSPIRE ADVISORS, LLC | 0.10% | 0.01% | 158,244 | 818 | 0.52% | 92,367 | Jun 30, 2024 |
| WEALTH ADVISORY SOLUTIONS, LLC | 0.09% | 0.02% | 151,000 | - | - | 88,139 | Jun 30, 2024 |
| ARKADIOS WEALTH ADVISORS | 0.09% | 0.01% | 150,000 | 50,000 | 50.00% | 87,555 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.07% | 0.00% | 117,754 | 117,754 | 100.00% | 68,733 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.00% | 100,099 | 100,099 | 100.00% | 58,000 | Jun 30, 2024 |
Citius Pharmaceuticals's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 6.38% of the company's total share outstanding, currently valued at $5.93M. The top 10 institutional shareholders own together 16.43% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6.38% | 0.07% | 10,156,000 | 10,156,000 | 100.00% | 5,928,057 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.13% | 0.02% | 201,876 | 201,876 | 100.00% | 117,835 | Jun 30, 2024 |
| WEALTH ADVISORY SOLUTIONS, LLC | 0.09% | 0.02% | 151,000 | - | - | 88,139 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.24% | 0.01% | 389,469 | 389,469 | 100.00% | 227,333 | Jun 30, 2024 |
| INSPIRE ADVISORS, LLC | 0.10% | 0.01% | 158,244 | 818 | 0.52% | 92,367 | Jun 30, 2024 |
| KEYNOTE FINANCIAL SERVICES LLC | 0.01% | 0.01% | 17,500 | - | - | 10,215 | Jun 30, 2024 |
| HORST & GRABEN WEALTH MANAGEMENT LLC | 0.05% | 0.01% | 75,722 | - | - | 44,199 | Jun 30, 2024 |
| 0.01% | 0.01% | 9,155 | 9,155 | 100.00% | 7,782 | Jun 30, 2024 | |
| ARKADIOS WEALTH ADVISORS | 0.09% | 0.01% | 150,000 | 50,000 | 50.00% | 87,555 | Jun 30, 2024 |
| MILLER INVESTMENT MANAGEMENT, LP | 0.03% | 0.00% | 50,000 | - | - | 29,185 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 275,000 | 275,000 | 100.00% | 160,518 | Jun 30, 2024 |
| MEASURED WEALTH PRIVATE CLIENT GROUP, LLC | 0.01% | 0.00% | 10,000 | - | - | 5,837 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.59% | 0.00% | 932,333 | - | - | 544,066 | Jun 30, 2024 |
| ETHOS FINANCIAL GROUP, LLC | 0.01% | 0.00% | 10,000 | - | - | 6,000 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 49,820 | 49,820 | 100.00% | 29,080 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.03% | 0.00% | 47,554 | 47,554 | 100.00% | 27,757 | Jun 30, 2024 |
| TCG ADVISORY SERVICES, LLC | 0.02% | 0.00% | 30,000 | - | - | 17,511 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.29% | 0.00% | 2,048,860 | 2,048,860 | 100.00% | 1,195,920 | Jun 30, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 0.00% | 0.00% | 4,000 | - | - | 2,335 | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.01% | 0.00% | 15,000 | - | - | 8,756 | Jun 30, 2024 |
The largest Citius Pharmaceuticals shareholder by % of total assets is ARMISTICE CAPITAL, LLC. The company owns 10.16M shares of Citius Pharmaceuticals (CTXR), representing 0.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6.38% | 0.07% | 10,156,000 | 10,156,000 | 100.00% | 5,928,057 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.29% | 0.00% | 2,048,860 | 2,048,860 | 100.00% | 1,195,920 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.75% | 0.00% | 1,186,559 | 1,099,074 | 1256.30% | 692,595 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.24% | 0.01% | 389,469 | 389,469 | 100.00% | 227,333 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 275,000 | 275,000 | 100.00% | 160,518 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.15% | 0.00% | 230,970 | 230,970 | 100.00% | 134,818 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.13% | 0.02% | 201,876 | 201,876 | 100.00% | 117,835 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.07% | 0.00% | 117,754 | 117,754 | 100.00% | 68,733 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.10% | - | 159,422 | 107,227 | 205.44% | 92,943 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.00% | 100,099 | 100,099 | 100.00% | 58,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 77,600 | 77,600 | 100.00% | 45,295 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 68,334 | 68,334 | 100.00% | 39,887 | Jun 30, 2024 |
| ARKADIOS WEALTH ADVISORS | 0.09% | 0.01% | 150,000 | 50,000 | 50.00% | 87,555 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 49,820 | 49,820 | 100.00% | 29,080 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.03% | 0.00% | 47,554 | 47,554 | 100.00% | 27,757 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 43,521 | 35,328 | 431.20% | 25,416 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.02% | 0.00% | 28,431 | 28,431 | 100.00% | 16,595 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 27,053 | 27,053 | 100.00% | 15,791 | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | 0.06% | 0.00% | 93,589 | 12,700 | 15.70% | 54,628 | Jun 30, 2024 |
| 0.01% | 0.01% | 9,155 | 9,155 | 100.00% | 7,782 | Jun 30, 2024 |
As of Jun 30 2024, Citius Pharmaceuticals's largest institutional buyer is ARMISTICE CAPITAL, LLC. The company purchased 10.16M stocks of CTXR, valued at $5.93M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.14% | - | 1,805,726 | -6,920,767 | -79.31% | 1,054,002 | Jun 30, 2024 |
| STATE STREET CORP | 0.37% | - | 581,797 | -1,627,767 | -73.67% | 339,595,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.03% | 0.00% | 1,646,297 | -1,299,197 | -44.11% | 961,171 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.98% | 0.00% | 6,327,257 | -677,862 | -9.68% | 3,693,220 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -484,649 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.01% | - | 14,631 | -305,730 | -95.43% | 8,540 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.05% | - | 76,073 | -280,921 | -78.69% | 44,404 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 9,740 | -181,927 | -94.92% | 5,686 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.02% | - | 30,042 | -126,811 | -80.85% | 17,543 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -86,431 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -77,606 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.00% | - | 1,134 | -76,856 | -98.55% | 1,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | - | 62,779 | -71,834 | -53.36% | 36,663 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.00% | - | 2,984 | -66,631 | -95.71% | 1,742 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -66,297 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.66% | 0.00% | 1,055,038 | -65,251 | -5.82% | 615,826,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 37,817 | -56,651 | -59.97% | 22,000 | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -56,355 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 3,041 | -48,183 | -94.06% | 1,775 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -47,889 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Citius Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -6.92M shares of CTXR, valued at $1.05M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6.38% | 0.07% | 10,156,000 | 10,156,000 | 100.00% | 5,928,057 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.29% | 0.00% | 2,048,860 | 2,048,860 | 100.00% | 1,195,920 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.24% | 0.01% | 389,469 | 389,469 | 100.00% | 227,333 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.17% | 0.00% | 275,000 | 275,000 | 100.00% | 160,518 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.15% | 0.00% | 230,970 | 230,970 | 100.00% | 134,818 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.13% | 0.02% | 201,876 | 201,876 | 100.00% | 117,835 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.07% | 0.00% | 117,754 | 117,754 | 100.00% | 68,733 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.06% | 0.00% | 100,099 | 100,099 | 100.00% | 58,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.05% | 0.00% | 77,600 | 77,600 | 100.00% | 45,295 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 68,334 | 68,334 | 100.00% | 39,887 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.03% | 0.00% | 49,820 | 49,820 | 100.00% | 29,080 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.03% | 0.00% | 47,554 | 47,554 | 100.00% | 27,757 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.02% | 0.00% | 28,431 | 28,431 | 100.00% | 16,595 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.02% | - | 27,053 | 27,053 | 100.00% | 15,791 | Jun 30, 2024 |
| 0.01% | 0.01% | 9,155 | 9,155 | 100.00% | 7,782 | Jun 30, 2024 | |
| MACQUARIE GROUP LTD | 0.00% | - | 6,887 | 6,887 | 100.00% | 4,020 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 5,464 | 5,464 | 100.00% | 3,189 | Jun 30, 2024 |
Citius Pharmaceuticals's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 10.16M shares, valued at $5.93M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -484,649 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -86,431 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -77,606 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -66,297 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -56,355 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -47,889 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -41,020 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -30,231 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -15,649 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -13,523 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -11,673 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -11,250 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -11,106 | -100.00% | - | Jun 30, 2024 |
| SHARED VISION WEALTH GROUP LLC | - | - | - | -10,700 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -10,148 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -4,144 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -3,036 | -100.00% | - | Jun 30, 2024 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -177 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -18 | -100.00% | - | Jun 30, 2024 |
Citius Pharmaceuticals's largest sold out institutional shareholder by shares sold is NUVEEN ASSET MANAGEMENT, LLC, sold -0.48M shares, valued at -, as of undefined.
Citius Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.20% | 106,287 | - | - | Mar 31, 2024 |
| PERRITT FUNDS INC | 0.20% | 25,000 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 200,965 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 19,107 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,254 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 6,097,498 | -1,950,975 | -24.24% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 356,994 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,318,718 | 56,549 | 4.48% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 10,148 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 78,774 | -6,920 | -8.08% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 111,428 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 7,925 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 47,889 | -3,988 | -7.69% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 16,538 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,060 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 37,800 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,704 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 66,399 | 12,543 | 23.29% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 8,153 | 2,100 | 34.69% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 4,807,041 | 212,643 | 4.63% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,122 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 531,333 | 56,906 | 11.99% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 19,298 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 222,206 | 339 | 0.15% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 5,000 | - | - | Mar 28, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 67,528 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 177,420 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 47,162 | -190 | -0.40% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 484,649 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 22,936 | - | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 19,776 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 556 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 17,486 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 687 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 22,999 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,045 | 9 | 0.87% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 19,608 | 3,548 | 22.09% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 18,007 | 2,123 | 13.37% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,885 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 73 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 44,360 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,809 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 102,400 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 13,923 | -56 | -0.40% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 771 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 90,530 | -1,508 | -1.64% | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 62,211 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 45,485 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 10,143 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 40,431 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 98,256 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 14,579 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 17,238 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 11,887 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 11,188 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,642 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1 | - | - | Mar 31, 2024 |
Citius Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 106.29K shares, compromising 0.20% of its total assets.
Citius Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 33 | -54.17% |
| 31 Mar, 24 | 72 | -4.00% |
| 31 Dec, 23 | 75 | -1.32% |
| 30 Sep, 23 | 76 | -2.56% |
| 30 Jun, 23 | 78 | 32.20% |
| 31 Mar, 23 | 59 | 7.27% |
| 31 Dec, 22 | 55 | -1.79% |
| 30 Sep, 22 | 56 | -1.75% |
| 30 Jun, 22 | 57 | -24.00% |
| 31 Mar, 22 | 75 | -5.06% |
| 31 Dec, 21 | 79 | 5.33% |
| 30 Sep, 21 | 75 | - |
| 30 Jun, 21 | 75 | 97.37% |
| 31 Mar, 21 | 38 | 72.73% |
| 31 Dec, 20 | 22 | 37.50% |
| 30 Sep, 20 | 16 | 23.08% |
| 30 Jun, 20 | 13 | 30.00% |
| 31 Mar, 20 | 10 | 11.11% |
| 31 Dec, 19 | 9 | -18.18% |
| 30 Sep, 19 | 11 | 10.00% |
| 30 Jun, 19 | 10 | -9.09% |
| 31 Mar, 19 | 11 | 22.22% |
| 31 Dec, 18 | 9 | -10.00% |
| 30 Sep, 18 | 10 | 66.67% |
| 30 Jun, 18 | 6 | - |
| 31 Mar, 18 | 6 | -14.29% |
| 31 Dec, 17 | 7 | 40.00% |
| 30 Sep, 17 | 5 | - |
As of 30 Jun 24, 33 institutions are holding Citius Pharmaceuticals's shares, representing a decrease of -54.17% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,777,758 | -89.71% |
| 31 Mar, 24 | 26,999,770 | 0.67% |
| 31 Dec, 23 | 26,820,000 | 7.67% |
| 30 Sep, 23 | 24,909,141 | -1.58% |
| 30 Jun, 23 | 25,308,481 | 75.37% |
| 31 Mar, 23 | 14,431,359 | 1.51% |
| 31 Dec, 22 | 14,216,416 | 3.89% |
| 30 Sep, 22 | 13,684,713 | -9.62% |
| 30 Jun, 22 | 15,140,695 | -37.21% |
| 31 Mar, 22 | 24,114,645 | -1.81% |
| 31 Dec, 21 | 24,559,746 | -2.11% |
| 30 Sep, 21 | 25,088,973 | -0.26% |
| 30 Jun, 21 | 25,154,174 | 132.33% |
| 31 Mar, 21 | 10,826,852 | 497.24% |
| 31 Dec, 20 | 1,812,813 | 72.65% |
| 30 Sep, 20 | 1,049,987 | 8.36% |
| 30 Jun, 20 | 968,999 | -54.64% |
| 31 Mar, 20 | 2,136,421 | 211.77% |
| 31 Dec, 19 | 685,262 | -81.28% |
| 30 Sep, 19 | 3,660,678 | 485.72% |
| 30 Jun, 19 | 624,988 | 77.66% |
| 31 Mar, 19 | 351,789 | -62.06% |
| 31 Dec, 18 | 927,177 | 264.57% |
| 30 Sep, 18 | 254,318 | -51.54% |
| 30 Jun, 18 | 524,805 | -24.95% |
| 31 Mar, 18 | 699,236 | 194.12% |
| 31 Dec, 17 | 237,736 | 570.30% |
| 30 Sep, 17 | 35,467 | - |
Citius Pharmaceuticals (CTXR) has 2.78M shares outstanding as of 30 Jun 24, down -89.71% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.75% | 0.61% |
| 31 Mar, 24 | 16.99% | 5.97% |
| 31 Dec, 23 | 16.87% | 6.43% |
| 30 Sep, 23 | 16.20% | 5.41% |
| 30 Jun, 23 | 17.30% | 17.77% |
| 31 Mar, 23 | 9.87% | 10.44% |
| 31 Dec, 22 | 9.72% | 11.08% |
| 30 Sep, 22 | 9.37% | 8.73% |
| 30 Jun, 22 | 10.36% | 3.80% |
| 31 Mar, 22 | 16.51% | 5.84% |
| 31 Dec, 21 | 16.82% | 3.15% |
| 30 Sep, 21 | 23.10% | 6.87% |
| 30 Jun, 21 | 18.34% | 14.42% |
| 31 Mar, 21 | 11.28% | 106.01% |
| 31 Dec, 20 | 3.26% | 45.38% |
| 30 Sep, 20 | 2.68% | 49.41% |
| 30 Jun, 20 | 2.33% | 6.01% |
| 31 Mar, 20 | 6.23% | 113.02% |
| 31 Dec, 19 | 2.35% | 0.71% |
| 30 Sep, 19 | 18.16% | 224.98% |
| 30 Jun, 19 | 2.84% | 78.40% |
| 31 Mar, 19 | 1.90% | 6.99% |
| 31 Dec, 18 | 5.22% | 92.94% |
| 30 Sep, 18 | 2.37% | 9.81% |
| 30 Jun, 18 | 4.92% | 10.05% |
| 31 Mar, 18 | 7.00% | 91.64% |
| 31 Dec, 17 | 2.76% | 660.18% |
| 30 Sep, 17 | 0.65% | - |
As of 30 Jun 24, Citius Pharmaceuticals is held by 1.75% institutional shareholders, representing a 0.61% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -67.86% |
| 31 Mar, 24 | 28 | -24.32% |
| 31 Dec, 23 | 37 | 32.14% |
| 30 Sep, 23 | 28 | -39.13% |
| 30 Jun, 23 | 46 | 84.00% |
| 31 Mar, 23 | 25 | -7.41% |
| 31 Dec, 22 | 27 | 28.57% |
| 30 Sep, 22 | 21 | -4.55% |
| 30 Jun, 22 | 22 | -21.43% |
| 31 Mar, 22 | 28 | -22.22% |
| 31 Dec, 21 | 36 | -10.00% |
| 30 Sep, 21 | 40 | -32.20% |
| 30 Jun, 21 | 59 | 84.38% |
| 31 Mar, 21 | 32 | 88.24% |
| 31 Dec, 20 | 17 | 30.77% |
| 30 Sep, 20 | 13 | 30.00% |
| 30 Jun, 20 | 10 | 66.67% |
| 31 Mar, 20 | 6 | 50.00% |
| 31 Dec, 19 | 4 | -42.86% |
| 30 Sep, 19 | 7 | 133.33% |
| 30 Jun, 19 | 3 | -57.14% |
| 31 Mar, 19 | 7 | 40.00% |
| 31 Dec, 18 | 5 | -16.67% |
| 30 Sep, 18 | 6 | 200.00% |
| 30 Jun, 18 | 2 | -50.00% |
| 31 Mar, 18 | 4 | -20.00% |
| 31 Dec, 17 | 5 | - |
| 30 Sep, 17 | 5 | - |
9 institutional shareholders have increased their position in CTXR stock as of 30 Jun 24 compared to 28 in the previous quarter (a -67.86% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -65.22% |
| 31 Mar, 24 | 23 | 91.67% |
| 31 Dec, 23 | 12 | -36.84% |
| 30 Sep, 23 | 19 | 35.71% |
| 30 Jun, 23 | 14 | - |
| 31 Mar, 23 | 14 | 75.00% |
| 31 Dec, 22 | 8 | -27.27% |
| 30 Sep, 22 | 11 | -42.11% |
| 30 Jun, 22 | 19 | -20.83% |
| 31 Mar, 22 | 24 | - |
| 31 Dec, 21 | 24 | 33.33% |
| 30 Sep, 21 | 18 | 200.00% |
| 30 Jun, 21 | 6 | 500.00% |
| 31 Mar, 21 | 1 | - |
| 31 Dec, 20 | - | -100.00% |
| 30 Sep, 20 | 1 | - |
| 30 Jun, 20 | 1 | - |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | - | -100.00% |
| 30 Jun, 19 | 1 | -50.00% |
| 31 Mar, 19 | 2 | - |
| 31 Dec, 18 | - | -100.00% |
| 30 Sep, 18 | 1 | -50.00% |
| 30 Jun, 18 | 2 | - |
| 31 Mar, 18 | - | -100.00% |
| 31 Dec, 17 | 1 | - |
| 30 Sep, 17 | - | - |
8 institutional shareholders have reduced their position in CTXR stock as of 30 Jun 24 compared to 23 in the previous quarter (a -65.22% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 33 | -54.17% | 2,777,758 | -89.71% | 1.75% | 0.61% | 9 | -67.86% | 8 | -65.22% |
| 31 Mar, 24 | 72 | -4.00% | 26,999,770 | 0.67% | 16.99% | 5.97% | 28 | -24.32% | 23 | 91.67% |
| 31 Dec, 23 | 75 | -1.32% | 26,820,000 | 7.67% | 16.87% | 6.43% | 37 | 32.14% | 12 | -36.84% |
| 30 Sep, 23 | 76 | -2.56% | 24,909,141 | -1.58% | 16.20% | 5.41% | 28 | -39.13% | 19 | 35.71% |
| 30 Jun, 23 | 78 | 32.20% | 25,308,481 | 75.37% | 17.30% | 17.77% | 46 | 84.00% | 14 | - |
| 31 Mar, 23 | 59 | 7.27% | 14,431,359 | 1.51% | 9.87% | 10.44% | 25 | -7.41% | 14 | 75.00% |
| 31 Dec, 22 | 55 | -1.79% | 14,216,416 | 3.89% | 9.72% | 11.08% | 27 | 28.57% | 8 | -27.27% |
| 30 Sep, 22 | 56 | -1.75% | 13,684,713 | -9.62% | 9.37% | 8.73% | 21 | -4.55% | 11 | -42.11% |
| 30 Jun, 22 | 57 | -24.00% | 15,140,695 | -37.21% | 10.36% | 3.80% | 22 | -21.43% | 19 | -20.83% |
| 31 Mar, 22 | 75 | -5.06% | 24,114,645 | -1.81% | 16.51% | 5.84% | 28 | -22.22% | 24 | - |
| 31 Dec, 21 | 79 | 5.33% | 24,559,746 | -2.11% | 16.82% | 3.15% | 36 | -10.00% | 24 | 33.33% |
| 30 Sep, 21 | 75 | - | 25,088,973 | -0.26% | 23.10% | 6.87% | 40 | -32.20% | 18 | 200.00% |
| 30 Jun, 21 | 75 | 97.37% | 25,154,174 | 132.33% | 18.34% | 14.42% | 59 | 84.38% | 6 | 500.00% |
| 31 Mar, 21 | 38 | 72.73% | 10,826,852 | 497.24% | 11.28% | 106.01% | 32 | 88.24% | 1 | - |
| 31 Dec, 20 | 22 | 37.50% | 1,812,813 | 72.65% | 3.26% | 45.38% | 17 | 30.77% | - | -100.00% |
| 30 Sep, 20 | 16 | 23.08% | 1,049,987 | 8.36% | 2.68% | 49.41% | 13 | 30.00% | 1 | - |
| 30 Jun, 20 | 13 | 30.00% | 968,999 | -54.64% | 2.33% | 6.01% | 10 | 66.67% | 1 | - |
| 31 Mar, 20 | 10 | 11.11% | 2,136,421 | 211.77% | 6.23% | 113.02% | 6 | 50.00% | 1 | - |
| 31 Dec, 19 | 9 | -18.18% | 685,262 | -81.28% | 2.35% | 0.71% | 4 | -42.86% | 1 | - |
| 30 Sep, 19 | 11 | 10.00% | 3,660,678 | 485.72% | 18.16% | 224.98% | 7 | 133.33% | - | -100.00% |
| 30 Jun, 19 | 10 | -9.09% | 624,988 | 77.66% | 2.84% | 78.40% | 3 | -57.14% | 1 | -50.00% |
| 31 Mar, 19 | 11 | 22.22% | 351,789 | -62.06% | 1.90% | 6.99% | 7 | 40.00% | 2 | - |
| 31 Dec, 18 | 9 | -10.00% | 927,177 | 264.57% | 5.22% | 92.94% | 5 | -16.67% | - | -100.00% |
| 30 Sep, 18 | 10 | 66.67% | 254,318 | -51.54% | 2.37% | 9.81% | 6 | 200.00% | 1 | -50.00% |
| 30 Jun, 18 | 6 | - | 524,805 | -24.95% | 4.92% | 10.05% | 2 | -50.00% | 2 | - |
| 31 Mar, 18 | 6 | -14.29% | 699,236 | 194.12% | 7.00% | 91.64% | 4 | -20.00% | - | -100.00% |
| 31 Dec, 17 | 7 | 40.00% | 237,736 | 570.30% | 2.76% | 660.18% | 5 | - | 1 | - |
| 30 Sep, 17 | 5 | - | 35,467 | - | 0.65% | - | 5 | - | - | - |
Citius Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Citius Pharmaceuticals's stock was made by Mazur Leonard L on Apr 05 2024, selling 1,165,048 shares at $1.42 per share (valued at $1.65M).
Citius Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 1 | - | - |
| Q4 2023 | 8 | - | - |
| Q1 2023 | 1 | - | - |
| Q4 2022 | 9 | - | - |
| Q4 2021 | 10 | - | - |
| Q3 2021 | 9 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | 8 | - | - |
| Q3 2020 | 6 | - | - |
| Q4 2019 | 8 | - | - |
| Q3 2019 | 4 | - | - |
| Q2 2019 | 4 | - | - |
| Q3 2018 | 12 | - | - |
| Q1 2018 | 3 | - | - |
| Q4 2017 | 1 | 3 | 33.33% |
| Q3 2017 | 13 | 1 | 1300.00% |
| Q2 2016 | 4 | 1 | 400.00% |
| Q1 2016 | 13 | 3 | 433.33% |
| Q4 2015 | - | 2 | - |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Citius Pharmaceuticals's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 4 | - | - |
| Q2 2019 | 4 | - | - |
| Q3 2018 | 2 | - | - |
| Q1 2018 | 3 | - | - |
| Q4 2017 | 1 | - | - |
| Q3 2017 | 4 | - | - |
| Q2 2016 | - | - | - |
| Q1 2016 | 1 | - | - |
| Q4 2015 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Citius Pharmaceuticals's stocks.
Citius Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| OCUP | Ocuphire Pharma, Inc. |
| BLRX | BioLineRx Ltd. |
| FBIO | Fortress Biotech, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| ARDX | Ardelyx, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| IBRX | ImmunityBio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| EYEN | Eyenovia, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| GRTX | Galera Therapeutics, Inc. |
CTXR Ownership FAQ
Who Owns Citius Pharmaceuticals?
Citius Pharmaceuticals is owned by institutional shareholders (1.75%), insiders (6.81%), and public (91.44%). The largest institutional shareholder of Citius Pharmaceuticals is ARMISTICE CAPITAL, LLC (6.38% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.20% of total shares).
Who are the major institutional shareholders of Citius Pharmaceuticals?
Citius Pharmaceuticals's major institutional shareholders are ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BLACKROCK INC., and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 13.82% of the company's share outstanding.
How many Citius Pharmaceuticals shareholders are there?
As of Jun 2024, there are 33 institutional shareholders of Citius Pharmaceuticals.
What percentage of Citius Pharmaceuticals is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 10.16M shares of Citius Pharmaceuticals, representing 6.38% of the company's total shares outstanding, valued at $5.93M (as of Jun 2024).
What percentage of Citius Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 6.33M shares of Citius Pharmaceuticals (CTXR), compromising 3.98% of the company, valued at $3.69M.
What percentage of Citius Pharmaceuticals is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of Citius Pharmaceuticals. The company owns 2.05M of the company's shares outstanding (worth $1.2M).